Variant report
Variant | esv18372 |
---|---|
Chromosome Location | chr6:30359622-30363319 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000204590 | chromatin interactions |
ENSG00000204576 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs59632867 | chr6:30359624-30359625 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs560554041 | chr6:30359642-30359643 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs550417383 | chr6:30359644-30359645 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs532399412 | chr6:30359669-30359670 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs150997312 | chr6:30359689-30359690 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs2524204 | chr6:30359697-30359698 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs3094701 | chr6:30359702-30359703 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs548244750 | chr6:30359717-30359718 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs568097346 | chr6:30359732-30359733 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs533903001 | chr6:30359734-30359735 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs139625741 | chr6:30359772-30359773 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs114325236 | chr6:30359773-30359774 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs372707829 | chr6:30359794-30359795 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs538938062 | chr6:30359801-30359802 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs558870631 | chr6:30359803-30359804 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs575412743 | chr6:30359809-30359810 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs2524203 | chr6:30359893-30359894 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs116693412 | chr6:30359934-30359935 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs3094047 | chr6:30360031-30360032 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs540720903 | chr6:30360042-30360043 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs561675640 | chr6:30360066-30360067 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs3094700 | chr6:30360068-30360069 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
23 | rs3094046 | chr6:30360100-30360101 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs191345095 | chr6:30360113-30360114 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs9404965 | chr6:30360150-30360151 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs548046794 | chr6:30360154-30360155 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs116525760 | chr6:30360165-30360166 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs527355861 | chr6:30360194-30360195 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs377317272 | chr6:30360218-30360219 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs3130105 | chr6:30360244-30360245 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs373841435 | chr6:30360247-30360248 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs184144144 | chr6:30360260-30360261 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs539072830 | chr6:30360321-30360322 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs144593515 | chr6:30360323-30360324 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs57300249 | chr6:30360324-30360325 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs538549901 | chr6:30360345-30360346 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs576005919 | chr6:30360368-30360369 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs190654549 | chr6:30360369-30360370 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs540067786 | chr6:30360432-30360433 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs540364411 | chr6:30360467-30360468 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs2032134 | chr6:30360509-30360510 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs3094699 | chr6:30360512-30360513 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs141636363 | chr6:30360515-30360516 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs562886527 | chr6:30360516-30360517 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs115702186 | chr6:30360533-30360534 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs3094045 | chr6:30360602-30360603 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
47 | rs561723709 | chr6:30360607-30360608 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs527527547 | chr6:30360614-30360615 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs377407352 | chr6:30360615-30360616 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs193091948 | chr6:30360619-30360620 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 17133270 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 16790693 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21785460 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Gastric cancer | 17908304 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Schizophrenia | 19571809 | CNVD |
Schizophrenia | 19571808 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
abnormal development | 18461090 | CNVD |
Melanoma | 17363583 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16397240 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Systemic lupus erythematosus | 20877625 | CNVD |
Cleidocranial dysplasia | 18696259 | CNVD |
Holoprosencephaly | 21359414 | CNVD |
Liposarcoma | 21253554 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Fibroblasts | 20926602 | CNVD |
Breast cancer | 21364760 | CNVD |
Lung cancer | 21569311 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:30359000-30359800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
2 | chr6:30359000-30359800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
3 | chr6:30359000-30359800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
4 | chr6:30359200-30359800 | Enhancers | H1 Cell Line | embryonic stem cell |
5 | chr6:30359200-30359800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
6 | chr6:30359200-30359800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
7 | chr6:30359800-30364600 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
8 | chr6:30362000-30362200 | Bivalent Enhancer | ES-I3 Cell Line | embryonic stem cell |
9 | chr6:30362000-30362200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |